Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Montu Group
2 followers
Delcath Systems
1 follower
Zinzino
2 followers
ProFound Therapeutics
1 follower
Charlie Health
15 followers
Madrigal Pharmaceuticals
10 followers
CMR Surgical
7 followers
Zenas BioPharma
7 followers
Action Behavior Centers
6 followers
Harbor Health
2 followers
Cost Plus Drugs
2 followers
Vaxcyte
5 followers